Docetaxel

CAS NO.：114977-28-5

Specification: USP / EP / domestic registration standard

Registration status:

CDE Y20210000530 Status: I

Uses: antineoplastic botanical drugs for the treatment of metastatic breast cancer and non-small cell lung cancer.

Properties

Docetaxel is an anticancer and antitumor drug. It can be used to study antibiotics, cell biology, cell signal transduction, neuroscience, apoptosis and cell cycle. Docetaxel is also used to study hair loss caused by docetaxel chemotherapy, prevention and treatment of non-small cell lung cancer in patients with contraindicated standard chemotherapy.

CAS No.

114977-28-5

Formula

C43H53NO14

Molecular Mass

807.8790

Exact Mass

807.34700

PSA

224.45000

Logp

3.65050

IUPAC

[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

Matter Classification

organic

Category

Melting Point

186-192 °C

Density

1.37 g/cm3

Boiling Point

900.5ºC

Flash Point

498.4ºC

Appearance